FINASTERIDE Drug Patent Profile
✉ Email this page to a colleague
When do Finasteride patents expire, and what generic alternatives are available?
Finasteride is a drug marketed by Accord Hlthcare, Actavis Totowa, Actavis Totowa Teva, Alkem Labs Ltd, Aurobindo Pharma, Aurobindo Pharma Ltd, Cipla, Dr Reddys Labs Inc, Dr Reddys Labs Ltd, Gedeon Richter Usa, Hetero Labs Ltd Iii, Ivax Sub Teva Pharms, Mylan, Natco Pharma, Sun Pharm, Teva, Zydus Pharms Usa Inc, and Zydus Lifesciences. and is included in twenty-three NDAs.
The generic ingredient in FINASTERIDE is finasteride; tadalafil. There are fourteen drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the finasteride; tadalafil profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for FINASTERIDE?
- What are the global sales for FINASTERIDE?
- What is Average Wholesale Price for FINASTERIDE?
Summary for FINASTERIDE
| US Patents: | 0 |
| Applicants: | 18 |
| NDAs: | 23 |
| Finished Product Suppliers / Packagers: | 34 |
| Raw Ingredient (Bulk) Api Vendors: | 103 |
| Clinical Trials: | 78 |
| Patent Applications: | 3,500 |
| Drug Prices: | Drug price information for FINASTERIDE |
| Drug Sales Revenues: | Drug sales revenues for FINASTERIDE |
| DailyMed Link: | FINASTERIDE at DailyMed |
See drug prices for FINASTERIDE
Recent Clinical Trials for FINASTERIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Follicle Pharma Ltd | Phase 1 |
| Mohammed Abd El Mawgoud Amer | N/A |
| Vanderbilt University Medical Center | Phase 2 |
Pharmacology for FINASTERIDE
| Drug Class | 5-alpha Reductase Inhibitor |
| Mechanism of Action | 5-alpha Reductase Inhibitors |
Medical Subject Heading (MeSH) Categories for FINASTERIDE
Anatomical Therapeutic Chemical (ATC) Classes for FINASTERIDE
US Patents and Regulatory Information for FINASTERIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accord Hlthcare | FINASTERIDE | finasteride | TABLET;ORAL | 091643-001 | Nov 5, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Sun Pharm | FINASTERIDE | finasteride | TABLET;ORAL | 090508-001 | Jul 1, 2013 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Aurobindo Pharma | FINASTERIDE | finasteride | TABLET;ORAL | 078341-001 | Oct 30, 2007 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Actavis Totowa Teva | FINASTERIDE | finasteride | TABLET;ORAL | 077914-001 | Mar 28, 2007 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Gedeon Richter Usa | FINASTERIDE | finasteride | TABLET;ORAL | 077251-001 | Dec 22, 2006 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
